These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 387810)

  • 41. Combined serotyping and biotyping of Serratia marcescens.
    Rubin SJ; Brock S; Chamberland M; Lyons RW
    J Clin Microbiol; 1976 Jun; 3(6):582-5. PubMed ID: 780372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serological study of bacterial flagellar hooks.
    Kagawa H; Asakura S; Iino T
    J Bacteriol; 1973 Mar; 113(3):1474-81. PubMed ID: 4120608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Serratia marcescens infections in a hospital: typing of isolated strains].
    Yde M
    Arch Belg; 1989; 47(5-6):189-210. PubMed ID: 2700064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of RAPD-PCR as a typing method for Serratia marcescens.
    Hejazi A; Keane CT; Falkiner FR
    J Med Microbiol; 1997 Nov; 46(11):913-9. PubMed ID: 9368531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotyping of Serratia marcescens: determination of serogroup (O) antigens and serological cross-reactions.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1978 Jan; 240(1):30-56. PubMed ID: 76382
    [No Abstract]   [Full Text] [Related]  

  • 47. Mass Spectrometry-Based Escherichia coli H Antigen/Flagella Typing: Validation and Comparison with Traditional Serotyping.
    Cheng K; She YM; Chui H; Domish L; Sloan A; Hernandez D; McCorrister S; Ma J; Xu B; Reimer A; Knox JD; Wang G
    Clin Chem; 2016 Jun; 62(6):839-47. PubMed ID: 27052506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit.
    Villarino ME; Jarvis WR; O'Hara C; Bresnahan J; Clark N
    J Clin Microbiol; 1989 Nov; 27(11):2433-6. PubMed ID: 2681247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunochemical characterization of two new O serotypes of Serratia marcescens (O27 and O28).
    Aucken HM; Wilkinson SG; Pitt TL
    FEMS Microbiol Lett; 1996 Apr; 138(1):77-82. PubMed ID: 8674974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antigenic study of "Serratia marcescens" isolated in France.II.--Characterization of O antigens and description of 5 new O factors, occurrence of serotypes and labelling of new H factors (author's transl)].
    Le Minor S; Pigache F
    Ann Microbiol (Paris); 1978 Oct; 129 B(3):407-23. PubMed ID: 85425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [O and H antigens of "Levinea malonatica" (author's transl)].
    Popoff M; Richard C
    Ann Microbiol (Paris); 1975; 126B(1):17-23. PubMed ID: 1211719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of factor-H sera for the differentiation of the flagellar antigens of Escherichia coli serological variants].
    Ratiner IuA; Klimova ZV; Ulisko IN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 May; (5):16-20. PubMed ID: 3303759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens.
    Roemisch E; Kocka FE
    Am J Clin Pathol; 1976 Jul; 66(1):96-100. PubMed ID: 779447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. State of the art: typing of Serratia marcescens.
    Pitt TL
    J Hosp Infect; 1982 Mar; 3(1):9-14. PubMed ID: 6177740
    [No Abstract]   [Full Text] [Related]  

  • 55. Re-evaluation of the serotypes of Serratia marcescens and separation into two schemes based on lipopolysaccharide (O) and capsular polysaccharide (K) antigens.
    Aucken HM; Wilkinson SG; Pitt TL
    Microbiology (Reading); 1998 Mar; 144 ( Pt 3)():639-653. PubMed ID: 9534235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of strains of Serratia marcescens isolated from neonates with strains isolated from sporadic and epidemic infections in adults.
    Gaston MA; Hoffman PN; Pitt TL
    J Hosp Infect; 1986 Jul; 8(1):86-95. PubMed ID: 2875106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteriophage typing of clinically isolated Serratia marcescens.
    Hamilton RL; Brown WJ
    Appl Microbiol; 1972 Dec; 24(6):899-906. PubMed ID: 4568252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different O and K serotype distributions among clinical and environmental strains of Serratia marcescens.
    Aucken HM; Pitt TL
    J Med Microbiol; 1998 Dec; 47(12):1097-104. PubMed ID: 9856646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of pulsed-field gel electrophoresis to investigate an outbreak of Serratia marcescens infection in a neonatal intensive care unit.
    Jang TN; Fung CP; Yang TL; Shen SH; Huang CS; Lee SH
    J Hosp Infect; 2001 May; 48(1):13-9. PubMed ID: 11358466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of MALDI-TOF mass spectrometry to detect nosocomial outbreaks of Serratia marcescens and Citrobacter freundii.
    Rödel J; Mellmann A; Stein C; Alexi M; Kipp F; Edel B; Dawczynski K; Brandt C; Seidel L; Pfister W; Löffler B; Straube E
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):581-591. PubMed ID: 30680577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.